Diltiazem use tied to serious bleeding risk in atrial fibrillation patients on apixaban or rivaroxaban: JAMA Medha Baranwal26 April 2024 9:45 AM ISTUSA: A recent study published in the Journal of the American Medical Association (JAMA) has revealed an increased risk of serious bleeding compared...
IPC flags ADR linked to Nimesulide, Cefuroxime, Dutasteride plus Tamsulosin and some beta-blockers Roshni Dhar15 April 2024 5:30 PM ISTThe Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert, has revealed adverse drug reactions linked with the popular...
Health Bulletin 15/ April/ 2024 Roshni Dhar15 April 2024 4:36 PM ISTHere are the top health stories for the day:Three private hospitals in Telangana served notices sue to high c-section ratesThe Health Department...
Drug Safety Alert: IPC Flags ADR Linked To Cefuroxime, Nimesulide, Dutasteride plus Tamsulosin and some Beta-blockers Susmita Roy14 April 2024 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert, has revealed adverse drug reactions linked with...
Zydus Healthcare gets CDSCO Panel Nod To study FDC Empagliflozin plus Metoprolol Succinate Dr. Divya Colin10 March 2024 5:45 PM ISTNew Delhi: The drug major Zydus Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Beta-blockers may reduce all-cause mortality in HFpEF patients Aditi19 Jan 2024 11:30 AM ISTAccording to the American and European heart failure guidelines, HFpEF is defined as a condition with LVEF >=50% and accompanying signs and...
Akum Pharmaceutical Gets CDSCO Panel Nod to Manufacture, Market Azelnidipine, Metoprolol FDC tablet Dr. Divya Colin3 Dec 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit raw data linked to CT result: CDSCO Panel Tells Akum Pharma on Azelnidipine, Metoprolol FDC drug Dr. Divya Colin4 Nov 2023 5:26 PM ISTNew Delhi: Based on the justification presented by Akum Pharmaceutical with respect to the clinical trial results of the fixed-dose combination...
Carvedilol better at lowering risk of arrhythmias among recipients of ICD compared to metaprolol Medha Baranwal22 Sept 2023 11:45 AM ISTUSA: Carvedilol can significantly reduce the risk of atrial arrhythmias (ATA) when compared to metoprolol in heart failure (HF) patients with...
Ajanta Pharma Gets CDSCO panel conditional Nod to Manufacture, Market Cardiovascular FDC Drug Dr. Divya Colin20 Aug 2023 5:30 PM ISTNew Delhi: Citing that the proposed FDC is already approved in higher strength, the Subject Expert Committee (SEC) functional under the Central Drug...
Ajanta Pharma Launches World's 1st FDC Met XL AMT for Patients with Uncontrolled Hypertension and Cardiovascular Co-morbidity in India MD Brand Connect8 Aug 2023 11:53 AM ISTAjanta Pharma, one of the leaders in the cardiology segment has announced the launch of Met XL AMT, a novel triple drug combination for the...
Submit Justification: CDSCO Tells Akum Pharma on Azelnidipine, Metoprolol FDC drug Dr. Divya Colin26 Jun 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Akum...
